2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with quinpirole in 1 studies
Studies (2-hexynyladenosine-5'-n-ethylcarboxamide) | Trials (2-hexynyladenosine-5'-n-ethylcarboxamide) | Recent Studies (post-2010) (2-hexynyladenosine-5'-n-ethylcarboxamide) | Studies (quinpirole) | Trials (quinpirole) | Recent Studies (post-2010) (quinpirole) |
---|---|---|---|---|---|
28 | 0 | 2 | 2,213 | 0 | 367 |
Protein | Taxonomy | 2-hexynyladenosine-5'-n-ethylcarboxamide (IC50) | quinpirole (IC50) |
---|---|---|---|
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cristalli, G; Morelli, M; Pinna, A; Wardas, J | 1 |
1 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and quinpirole
Article | Year |
---|---|
Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Dopamine Agonists; Immunohistochemistry; Limbic System; Male; Oxidopamine; Phenethylamines; Proto-Oncogene Proteins c-fos; Purinergic Antagonists; Purinergic P1 Receptor Agonists; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Triazoles | 1997 |